The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
PARIS, March 28, 2025 (GLOBE NEWSWIRE) -- Curium Pharma ("Curium"), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products ...
CapVest Partners is evaluating strategic alternatives for Curium Pharma, a French nuclear medicine company, according to four people familiar with the matter. A process is not formally underway; ...
Curium Pharma, the CapVest Partners-backed nuclear medicine imaging company, is poised to field first round bids early next week, people with knowledge of the matter told PE Hub. A process formally ...
BOSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Curium has established a legal entity in China, Curium Shanghai Pharmaceuticals Co., Ltd. (?????), representing a major milestone in Curium’s growth strategy ...
The impact of coronavirus on the economy took another turn this week after CapVest shelved its sale of nuclear medicine specialist Curium Pharma, blaming the outbreak. The London-based private equity ...
Fujifilm Holdings Corp. is entering the race for Curium Pharma, challenging buyout firms bidding for the French maker of medical imaging supplies in a deal that could fetch at least $3 billion, people ...
Scintimun is an internationally approved product [2] and has previously been manufactured and distributed by Curium Pharma through an out-license from Telix via the acquisition of TheraPharm in 2020 ...
LONDON/HONG, KONG – Fujifilm Holdings Corp. is entering the race for Curium Pharma, challenging buyout firms bidding for the French maker of medical imaging supplies in a deal that could fetch at ...
Nasdaq: TLX , Telix, the Company) today announces that it has entered into an agreement with Curium Pharma for the transfer of marketing and distribution rights for Scintimun® (99mTc-besilesomab, also ...
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results